dostarlimab
gsk
['dostarlimab']
31% reduction in the risk of progression or death with addition of dostarlimab to chemotherapy in patients with advanced endometrial cancer. #asco23 #asco2023 #asco #endometrialcancer #research 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"